2018 Lipoprotein Metabolism Gordon Research Conference and Gordon Research Seminar

2018年脂蛋白代谢戈登研究会议暨戈登研究研讨会

基本信息

批准号：
9542570
负责人：
Cheryl Lea Wellington
金额：
$ 1.5万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-04-01 至 2019-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9542570
关键词：
Address Affect Alzheimer&apos s Disease Antibody Therapy Apolipoproteins B Area Basic Science Biochemistry Bioinformatics Biological Biological Models Biology Blood Vessels Brain Cardiovascular Diseases Cells Chronic Disease Clinical Consultations Country Dementia Development Diagnosis Diné Nation Discipline Disease Dyslipidemias Ensure Ethnic group Event Fostering Future Genetic Genetic study Genomic medicine Genomics Goals Heart Diseases High Density Lipoproteins Homeostasis Hour Human Human Engineering Hyperlipidemia Individual International Interpersonal Relations Intestines Knowledge Lipids Lipoproteins Metabolism Modeling Molecular National Institute of Neurological Disorders and Stroke Nerve Degeneration Neurodegenerative Disorders Oral Participant Pathogenesis Pathway interactions Patients Peripheral Population Heterogeneity Postdoctoral Fellow Prevention Process Proteomics Public Health Relationship-Building Research Research Personnel Residual state Risk Schedule Science Scientific Inquiry Scientist Site Structure Systems Biology Technology Therapeutic Therapeutic Studies Time Tissue Engineering Tissues Translating Translational Research Translations Vascular Dementia Vascular Diseases Woman animal tissue cardiometabolism cardiovascular health career design ethnic minority population frontier gender diversity genome sciences graduate student gut microbiota health disparity human tissue improved innovation interest knowledge base lipid metabolism lipoprotein disorder meetings member metabolic abnormality assessment novel diagnostics novel therapeutics posters programs social success symposium translational impact uptake vascular contributions

项目摘要

Abstract We request partial support for the 2018 Lipoprotein Metabolism Gordon Research Conference (GRC) and Gordon Research Seminar (GRS), entitled The “New Breakthroughs in Lipid and Lipoprotein Metabolism in Alzheimer’s and Cardiometabolic Diseases”, at Waterville Valley Conference Center, NH on June 9-15, 2018. The Co-Chairs, Drs. Alan Remaley and Cheryl Wellington, in consultation with past chair, the 2018 Vice Chairs (Drs. Mahmood Hussain and Kiran Musunuru), and field leaders, have planned nine oral sessions to promote dialogue among established and emerging leaders in cardiovascular disease and neurodegeneration: Session 1- Keynote Address on New Pathways in Cellular Lipid Homeostasis in the Brain and Other Tissues, and Short Talks, Session 2- Lipoprotein Metabolism in the Brain, Session 3- Gut Microbiota and Intestinal Lipid Metabolism, and Short Talks, Session 4- Tissue Engineering: New human experimental platforms for the study of vascular disease, Session 5- Genomics of Dementia and Cardiovascular Disease, Session 6- HDL Structure and Function, Session 7- ApoB-containing Lipoprotein Metabolism and Cellular Uptake Pathways, Session 8- Novel Therapies and Diagnostic Approaches for Vascular Lipoprotein Disorders, and Session 9- Selected Abstracts and Late Breaking Topics. The GRC will be preceded by the Lipoprotein Metabolism GRS, an international forum for presentation and discussion of frontier research by graduate students and postdoctoral fellows. Our GRC addresses a priority of the NINDS, namely the vascular contributions to dementia. 1) We bring together international leaders in lipoprotein metabolism in peripheral tissues and in the brain to promote interdisciplinary discussion on vascular contributions to neurodegenerative disorders. 2) Gender and diversity-related issues of genetics, biology, biochemistry and clinical manifestations of dyslipidemias are identified, satisfying the NINDS responsibility for addressing these issues in women and diverse populations. Ten of the 29 accepted speakers are women (34%), 5 are from minority ethnic groups (14%) and 18 (62%) are young investigators. Five accepted speakers are international, representing three countries outside the US. 3) Our conference includes diverse topics related to the causes, prevention, diagnosis and treatment of dyslipidemias from cardiovascular disease to dementia. 4) The NINDS is a new supporter of our meeting and we are honored to invite members of NINDS administration as attendees. 5) The Chairs and Co-Chairs place the highest priority on participation by trainees and early career individuals.

抽象的我们请求对 2018 年脂蛋白代谢戈登研究会议 (GRC) 提供部分支持戈登研究研讨会（GRS），题为“脂质和脂蛋白代谢的新突破” “阿尔茨海默病和心脏代谢疾病”，2018 年 6 月 9 日至 15 日在新罕布什尔州沃特维尔谷会议中心举行。联合主席 Alan Remaley 博士和 Cheryl Wellington 与前任主席、2018 年副主席协商（Mahmood Hussain 博士和 Kiran Musunuru 博士）和现场领导者计划了九场口头会议，以促进心血管疾病和神经退行性疾病领域老牌和新兴领导人之间的对话：会议 1- 关于大脑和其他组织细胞脂质稳态新途径的主题演讲，以及简短的演讲讲座，第 2 节 - 大脑中的脂蛋白代谢，第 3 节 - 肠道微生物群和肠道脂质新陈代谢和简短的谈话，第 4 节 - 组织工程：新的人体实验平台血管疾病研究，第 5 节 - 痴呆和心血管疾病的基因组学，第 6 节 - HDL 结构和功能，第 7 节 - 含 ApoB 的脂蛋白代谢和细胞摄取途径，第 8 节 - 血管脂蛋白疾病的新疗法和诊断方法，以及第 9 节 - 精选摘要和最新热点主题将在脂蛋白代谢 GRS 之前进行。研究生和讨论前沿研究的国际论坛我们的 GRC 致力于解决 NINDS 的一个优先事项，即对血管的贡献。 1) 我们汇集了外周组织脂蛋白代谢领域的国际领先者。脑促进关于血管对神经退行性疾病的贡献的跨学科讨论2)。与性别和多样性相关的遗传学、生物学、生物化学和临床表现问题血脂异常得到识别，履行了 NINDS 解决妇女和儿童中这些问题的责任接受的 29 名演讲者中有 10 名是女性（34%），5 名来自少数族裔群体。 (14%) 和 18 名 (62%) 是年轻研究者，其中 5 名演讲者是国际人士，代表 3 名。 3) 我们的会议包括与原因、预防、从心血管疾病到痴呆的血脂异常的诊断和治疗 4) NINDS 是一个新的。我们会议的支持者，我们很荣幸邀请 NINDS 管理人员作为与会者 5) 主席和联合主席高度重视学员和早期职业人士的参与。